LATEST BLOGS

Latest News

Natco launches Indian Stivarga Regorafenib 40mg Tablets under the brand name Regonat 40mg Tablets

Regonat 40mg Tablets: Generic version of Regorafenib Tablets now available in India Natco Pharma Limited has become the foremost Pharmaceutical Company in India who has launched the first generic version of Bayer AG invented drug Stivarga Regorafenib 40mg Tablets under...

Exelixis initiates Phase III trial of cabozantinib to treat (RCC) Renal Cell Carcinoma

Exelixis is commencing a Phase III pivotal trial to evaluate cabozantinib (CABOMETYX) for the treatment of patients with previously untreated advanced renal cell carcinoma (RCC). As part of the trial, cabozantinib will be evaluated in combination with nivolumab (Opdivo) and...

Natco India settles patent dispute with Onyx Therapeutics for blood cancer drug Carfilzomib

Natco has partnered with Breckenridge Pharmaceutical, which will market the product in the US. Indian Drug maker Natco Pharma on May 30th, 2019 said it has reached an out-of-court settlement in the US with Onyx Therapeutics over patent litigation related to the generic...

Novartis New launch Zolgensma, a gene therapy, will cost $2.1 million

Zolgensma from Novartis is the most expensive drug ever Approved via FDA this Friday Novartis The Federal Food and Drug Administration has authorized a gene remedy for a uncommon childhood disease that is now the most costly drug on the...

Indian Pharmaceutical Companies introduced new strength of Abiraterone Acetate under 500mg with New Packaging Labels

Abiraterone Acetate Tablets or Generic Zytiga Tablets are now available in a new strength i.e., 500 mg in each tablet, which is used in combination with prednisone to treat metastatic castration-resistant prostate cancer in men, that has spread to other...